Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on the Therapeutic Effect and Clinical Indicators of XingpiJieyu Formula in the Treatment of Severe Liver Depression and Spleen Deficiency Type Depression Based on Abnormal Mitochondrial Energy Metabolism Pathway

NCT07590609 is registered in ClinicalTrials.gov with Peking University Sixth Hospital as lead sponsor.

NCT NCT07590609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07590609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on the Therapeutic Effect and Clinical Indicators of XingpiJieyu Formula in the Treatment of Severe Liver Depression and Spleen Deficiency Type Depression Based on Abnormal Mitochondrial Energy Metabolism Pathway
Lead sponsor
Peking University Sixth Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 23, 2023
Completion date
January 31, 2026
Enrollment
150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver-stagnation and spleen-deficiency, severe major depression disorder